Management of Ischemic Heart Disease: Therapeutic Options and Future Directions–Official Satellite Symposium to the XVIIth Congress of the European Society of Cardiology Peter H.J.M. Dunselman OriginalPaper Pages: 209 - 209
Angina Pectoris in a Contemporary Population: Characteristics and Therapeutic Implications Carl J. Pepine OriginalPaper Pages: 211 - 216
Treatment of Chronic Myocardial Ischemia: Rationale and Treatment Options Peter F. Cohn OriginalPaper Pages: 217 - 223
Therapeutic Options and Cost Considerations in the Treatment of Ischemic Heart Disease John G.F. ClelandAndrew Walker OriginalPaper Pages: 225 - 232
A Comparative Study of Once-Daily Amlodipine versus Twice-Daily Diltiazem Controlled Release (CR) in the Treatment of Stable Angina Pectoris H.A.M. van KesterenA.J.A.M. Withagen OriginalPaper Pages: 233 - 237
Amlodipine versus Diltiazem CR in the Reduction of the Total Ischemic Burden: The Circadian Anti-Ischemia Program in Europe (CAPE) II Trial — Clinical Rationale and Methodology John E. Deanfield OriginalPaper Pages: 239 - 242
Management of Ischemic Heart Disease: Therapeutic Options and Future Directions Official Satellite Symposium to the XVIIth Congress of the European Society of Cardiology Marvin A. Konstam OriginalPaper Pages: 243 - 243